The Evolution of Alciply

In 2012, the person study looked at people that came in within six hours of onset of symptoms of stroke. And they did not show any difference in ICH between that there's a connective place that we can alciply which was again a pretty big takeaway from this study. The North test trial is unique in a sense that they really wanted to look at patients with mild stroke. And what they found was that there was no difference in efficacy or safety. But guess what? They used the dose of.4 mix per kid versus connective place versus the usual dose of alcipley .9 mix per kid. So now actually there's a part B of this trial that